Patrick Kwok‐Shing Ng

8.2k total citations
38 papers, 1.2k citations indexed

About

Patrick Kwok‐Shing Ng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Kwok‐Shing Ng has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Kwok‐Shing Ng's work include Cancer Genomics and Diagnostics (7 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Patrick Kwok‐Shing Ng is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Patrick Kwok‐Shing Ng collaborates with scholars based in United States, Hong Kong and China. Patrick Kwok‐Shing Ng's co-authors include Gordon B. Mills, Peter S. Nelson, Brett T. Marck, Steven P. Balk, Hongyun Wang, Shaoyong Chen, Alvin M. Matsumoto, Sen Chen, Glenn J. Bubley and Nicholas I. Simon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick Kwok‐Shing Ng

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Kwok‐Shing Ng United States 17 610 419 312 304 191 38 1.2k
Hidetoshi Kuruma Japan 19 544 0.9× 650 1.6× 225 0.7× 257 0.8× 94 0.5× 41 1.1k
Iván Plaza-Menacho United Kingdom 20 598 1.0× 241 0.6× 197 0.6× 490 1.6× 240 1.3× 27 1.3k
Shusuke Akamatsu Japan 21 692 1.1× 884 2.1× 573 1.8× 279 0.9× 122 0.6× 156 1.8k
Daniel P. Rakiec Switzerland 9 572 0.9× 454 1.1× 223 0.7× 178 0.6× 119 0.6× 11 1.0k
Livia Manzella Italy 23 878 1.4× 170 0.4× 283 0.9× 467 1.5× 242 1.3× 68 1.8k
Armelle Degeorges France 18 747 1.2× 404 1.0× 562 1.8× 776 2.6× 95 0.5× 34 1.6k
Mika K. Derynck United States 15 648 1.1× 308 0.7× 281 0.9× 553 1.8× 121 0.6× 34 1.5k
Sara A. Byron United States 18 1.3k 2.2× 223 0.5× 549 1.8× 375 1.2× 85 0.4× 48 1.9k
Teresina Amaro Portugal 19 540 0.9× 146 0.3× 213 0.7× 249 0.8× 199 1.0× 42 1.1k
Stephanie Greene United States 9 458 0.8× 563 1.3× 507 1.6× 443 1.5× 83 0.4× 18 1.3k

Countries citing papers authored by Patrick Kwok‐Shing Ng

Since Specialization
Citations

This map shows the geographic impact of Patrick Kwok‐Shing Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Kwok‐Shing Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Kwok‐Shing Ng more than expected).

Fields of papers citing papers by Patrick Kwok‐Shing Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Kwok‐Shing Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Kwok‐Shing Ng. The network helps show where Patrick Kwok‐Shing Ng may publish in the future.

Co-authorship network of co-authors of Patrick Kwok‐Shing Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Kwok‐Shing Ng. A scholar is included among the top collaborators of Patrick Kwok‐Shing Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Kwok‐Shing Ng. Patrick Kwok‐Shing Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Aaron, Jonathan E. Martin, Markus J. Bookland, et al.. (2025). A feasibility study of enzymatic methylation sequencing of cell-free DNA from cerebrospinal fluid of pediatric central nervous system tumor patients for molecular classification. Neuro-Oncology Advances. 7(1). vdaf159–vdaf159.
2.
Li, Jun, Wei Liu, Kamalika Mojumdar, et al.. (2024). A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies. Nature Cancer. 5(10). 1579–1595. 6 indexed citations
3.
Johnson, Amber M., Patrick Kwok‐Shing Ng, Michael Kahle, et al.. (2023). Actionability classification of variants of unknown significance correlates with functional effect. npj Precision Oncology. 7(1). 67–67. 6 indexed citations
4.
Saridogan, Turçin, Argun Akçakanat, Ming Zhao, et al.. (2023). Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific Reports. 13(1). 20223–20223. 12 indexed citations
5.
Doering, Christopher B., et al.. (2021). In Vivo HSC Gene Therapy with High-Level, Erythroid-Specific Expression of a Secreted SARS-CoV-2 Decoy Receptor. Molecular Therapy. 29(4). 91–92. 1 indexed citations
6.
Shariati, Maryam, Kurt W. Evans, Xiaofeng Zheng, et al.. (2021). Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 40(26). 4425–4439. 17 indexed citations
7.
Chen, Hu, Jun Li, Yumeng Wang, et al.. (2020). Comprehensive assessment of computational algorithms in predicting cancer driver mutations. Genome biology. 21(1). 43–43. 39 indexed citations
8.
Fang, Yong, Jun‐Jie Yin, Jian Chen, et al.. (2017). Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science Translational Medicine. 9(392). 170 indexed citations
9.
Kong, Kathleen, Patrick Kwok‐Shing Ng, & Kenneth L. Scott. (2017). Ba/F3 transformation assays. Oncotarget. 8(22). 35488–35489. 5 indexed citations
10.
Ip, Carman Ka Man, Jun Yin, Patrick Kwok‐Shing Ng, Shiaw‐Yih Lin, & Gordon B. Mills. (2016). Genomic-Glycosylation Aberrations in Tumor Initiation, Progression and Management. SHILAP Revista de lepidopterología. 3(4). 386–416. 3 indexed citations
11.
Grubbs, Elizabeth G., Patrick Kwok‐Shing Ng, Naifa L. Busaidy, et al.. (2014). RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 100(3). 788–793. 67 indexed citations
12.
Ng, Yuen‐Keng, Vivian Wai Yan Lui, Alfred S.L. Cheng, et al.. (2013). Full‐length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells. FEBS Letters. 587(5). 496–503. 7 indexed citations
13.
Ng, Patrick Kwok‐Shing, et al.. (2012). Identification of small RNAs in Mycobacterium smegmatis using heterologous Hfq. RNA. 19(1). 74–84. 24 indexed citations
14.
Ma, Brigette, Vivian Wai Yan Lui, Crystal S. F. Cheung, et al.. (2012). Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines. Investigational New Drugs. 31(1). 30–38. 7 indexed citations
15.
Cai, Changmeng, Sen Chen, Patrick Kwok‐Shing Ng, et al.. (2011). Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors. Cancer Research. 71(20). 6503–6513. 349 indexed citations
16.
Ng, Patrick Kwok‐Shing, Vivian Wai Yan Lui, Jialiang Li, et al.. (2011). FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Letters. 304(2). 97–106. 29 indexed citations
17.
Leung, P. Y., et al.. (2010). The involvement of N-G,N-G-dimethyarginine dimethylhydrolase 1 in the proliferative effect of Astragali radix on cardiac cells. Journal of Ethnopharmacology. 134(1). 130–135. 2 indexed citations
18.
Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Kevin Ki‐Wai Ho, et al.. (2010). Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. Oncogene. 30(9). 1127–1134. 48 indexed citations
19.
Yu, Richard Man Kit, et al.. (2007). Characterization of a hypoxia-responsive leptin receptor (omLepRL) cDNA from the marine medaka (Oryzias melastigma). Marine Pollution Bulletin. 54(6). 797–803. 42 indexed citations
20.
Koo, John, et al.. (1998). Random population-wide genetic damage induced in replicating cells treated with methotrexate. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 413(3). 251–264. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidetoshi Kuruma Breakdown of academic impact, for papers by Iván Plaza-Menacho Breakdown of academic impact, for papers by Shusuke Akamatsu Breakdown of academic impact, for papers by Daniel P. Rakiec Breakdown of academic impact, for papers by Livia Manzella Breakdown of academic impact, for papers by Armelle Degeorges Breakdown of academic impact, for papers by Mika K. Derynck Breakdown of academic impact, for papers by Sara A. Byron Breakdown of academic impact, for papers by Teresina Amaro Breakdown of academic impact, for papers by Stephanie Greene
Rankless by CCL
2026